OpenBiome

Kathryn Dzintars, PharmD, BCPS
OpenBiome is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

-- The first section of this topic is shown below --

INDICATIONS

FDA

Fecal microbiota transplantation (FMT) is considered an investigational new drug (IND), which typically requires an application to be filed; however, the FDA has released specific guidance related to these types of therapies.

-- To view the remaining sections of this topic, please or --

INDICATIONS

FDA

Fecal microbiota transplantation (FMT) is considered an investigational new drug (IND), which typically requires an application to be filed; however, the FDA has released specific guidance related to these types of therapies.

There's more to see -- the rest of this topic is available only to subscribers.

Last updated: February 1, 2017